MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.65 +3.11%

+$0.39 today

Market cap
$283.41M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.42M

Average 0.73M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$138.14M

FY 2025 · Annual

Investing Cash Flow

-$323.21M

FY 2025 · Annual

Financing Cash Flow

$469.82M

FY 2025 · Annual

+298.0% YoY

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(30.02M)(55.71M)(77.58M)(161.15M)
Depreciation & Amortization574K556K701K578K
Deferred Income Tax0000
Stock-Based Compensation0000
Change in Working Capital1.72M2.04M(3.07M)(12.84M)
Accounts Receivables0000
Inventory0000
Accounts Payables0000
Other Working Capital1.72M2.04M(3.07M)(12.84M)
Other Non-Cash Items1.14M1.11M1.13M35.27M
Operating Cash Flow(26.58M)(52.01M)(78.82M)(138.14M)
Capital Expenditures(746K)(462K)(770K)(473K)
Acquisitions (Net)0000
Purchases of Investments00(125.02M)(408.23M)
Sales of Investments0045M85.5M
Other Investing Activities0000
Investing Cash Flow(746K)(462K)(80.79M)(323.21M)
Debt Repayment0000
Common Stock Issued33.17M104.57M120.25M474.84M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities33.18M104.57M(2.19M)(5.02M)
Financing Cash Flow33.17M104.57M118.06M469.82M
Effect of Forex Changes21.81M027K0
Net Change in Cash27.67M52.1M(41.52M)8.48M
Free Cash Flow(27.32M)(52.47M)(79.59M)(138.61M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$161.2M
+ D&A$578.0K
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$12.8M
+ Other Non-Cash$35.3M
= Operating Cash Flow-$138.1M
- Capex-$473.0K
= Free Cash Flow-$138.6M

Analysis

FY2025 free cash flow is -$138.6M. FCF conversion is 86.0% of net income. Operating cash flow was -$138.1M, with capex of -$473.0K. The largest bridge item is Other Non-Cash at $35.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026

Does MPLT generate free cash flow?

MapLight Therapeutics, Inc. (MPLT) generated -$138.61M of free cash flow in fiscal 2025.

How much operating cash flow does MPLT produce?

Operating cash flow was -$138.14M, before capital expenditures of $473,000.00.